Cancer survival rates have improved in recent years, driven by advances in early detection, targeted therapies, and better understanding of tumour biology. The article highlights how innovations like molecular diagnostics, immunotherapy, and personalised treatment plans are reshaping patient outcomes.
Read the full article on New Straits Times
